These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2257995)

  • 1. Acute and chronic effects of hyperglycaemia on glucose metabolism.
    Yki-Järvinen H
    Diabetologia; 1990 Oct; 33(10):579-85. PubMed ID: 2257995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic effects of hyperglycaemia on glucose metabolism: implications for the development of new therapies.
    Yki-Järvinen H
    Diabet Med; 1997 Aug; 14 Suppl 3():S32-7. PubMed ID: 9272611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
    Christensen MB
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatic and peripheral insulin resistance as a cause of hyperglycemia in non-insulin-dependent (type 2) diabetes mellitus: a review].
    Bratusch-Marrain P; Waldhäusl W
    Wien Klin Wochenschr; 1987 Apr; 99(7):211-6. PubMed ID: 3296467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
    Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
    Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased intestinal glucose absorption and postprandial hyperglycaemia at the early step of glucose intolerance in Otsuka Long-Evans Tokushima Fatty rats.
    Fujita Y; Kojima H; Hidaka H; Fujimiya M; Kashiwagi A; Kikkawa R
    Diabetologia; 1998 Dec; 41(12):1459-66. PubMed ID: 9867213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glucose toxicity--pros and cons. Useful adaptation and common cause of insulin resistance in diabetic patients].
    Yki-Järvinen H
    Nord Med; 1996 Mar; 111(3):80-3. PubMed ID: 8628644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed onset of hyperglycaemia in a mouse model with impaired glucagon secretion demonstrates that dysregulated glucagon secretion promotes hyperglycaemia and type 2 diabetes.
    Gustavsson N; Seah T; Lao Y; Radda GK; Südhof TC; Han W
    Diabetologia; 2011 Feb; 54(2):415-22. PubMed ID: 20978738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats.
    Burcelin R; Eddouks M; Maury J; Kande J; Assan R; Girard J
    Diabetologia; 1995 Mar; 38(3):283-90. PubMed ID: 7758874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of activated glucose counterregulation on insulin requirements in insulin-dependent diabetes mellitus.
    Bolli GB; Perriello G
    Horm Metab Res Suppl; 1990; 24():87-96. PubMed ID: 2272633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
    Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
    Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Why is insulin release from beta cells insufficient in type 2 diabetes?].
    Grill V
    Tidsskr Nor Laegeforen; 2000 Sep; 120(23):2796-8. PubMed ID: 11107928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man.
    Del Prato S; Leonetti F; Simonson DC; Sheehan P; Matsuda M; DeFronzo RA
    Diabetologia; 1994 Oct; 37(10):1025-35. PubMed ID: 7851681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the role of the gut in diabetic hyperglucagonaemia.
    Lund A
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an update.
    Porte D; Kahn SE
    Am J Med; 1991 Jun; 90(6A):8S-14S. PubMed ID: 1872310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglycaemia is associated with impaired pulsatile insulin secretion: effect of basal insulin therapy.
    Meier JJ; Pennartz C; Schenker N; Menge BA; Schmidt WE; Heise T; Kapitza C; Veldhuis JD
    Diabetes Obes Metab; 2013 Mar; 15(3):258-63. PubMed ID: 23039360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antecedent chronic hyperglycaemia blocks phlorizin-induced insulin resistance in the dog.
    Koffler M; Imamura T; Santeusanio F; Helderman JH
    Diabetologia; 1988 Apr; 31(4):228-34. PubMed ID: 3384220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.